Medical Advocates
HIV Infection/Disease
  Cardiovascular Disease Risk Factors
 
General Reports
 Atherosclerosis
 Fat Redistribution
 ARV Drugs
 Low-Density Lipoprotein
Cocaine
 Lipodystrophy
Elevated LDL Cholesterol


 
HIV Cardiovascular Main Page Main New/Newsworthy  Home Page      
Last Update: February 17, 2018
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       

           Videos

 
  • Assessing Cardiovascular Risk for Persons with HIV Infection
    Judith Aberg, MD,

          Journal Papers, Abstracts, and Commentaries

 
Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
 Triant VA, Perez J, Regan S, et al
Circulation. 2018 Feb 14.
Abstract

Comparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients.
Neto LFDSP, Dias FR, Bressan FF, Santos CRO.
 Braz J Infect Dis. 2017 Jul 18.
Abstract

HIV Patient Systemic Mitochondrial Respiration Improves with Exercise.
Kocher M, McDermott M, Lindsey R 
AIDS Res Hum Retroviruses. 2017 May
Abstract


 Marijuana use impacts midlife cardiovascular events in HIV-infected men.
Lorenz DR, Dutta A, Mukerji SS, et al
Clin Infect Dis. 2017 Apr 25
Abstract

Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
Freiberg MS, Chang CH, Skanderson M,  et al
JAMA Cardiol. 2017 Apr 5
Abstract

Cardiovascular disease risk prediction in the HIV Outpatient Study.
Thompson-Paul AM, Lichtenstein KA, et al  
 Clin Infect Dis. 2016 Sep 9
Abstract

Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score
 Cortés YI, Reame N, Zeana C, et al
J Womens Health (Larchmt). 2016 Sep 9
Abstract

Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M, Hoogeveen RC, Hoepelman A,  et al
HIV Med. 2015 Aug 12. 
Abstract

Risk of Cardiovascular Events Associated with Current Exposure to HIV Antiretroviral Therapies in a US Veteran Population.
Desai M, Joyce V, Bendavid E, Olshen RA,  et al 
Clin Infect Dis. 2015 Apr 22.
Abstract

Metabolic disorders and cardiovascular risk in treatment-naïve HIV-infected patients of Sub-Saharan origin starting antiretrovirals: impact of westernized lifestyle.
Lacombe K, Eholié S, Krain A,  et al
AIDS Res Hum Retroviruses. 2015 Feb 24.
Abstract

Changing prevalence, profile, and outcomes of patients with HIV undergoing cardiac surgery in the United States.
Polanco A, Itagaki S, Chiang Y, Chikwe J.
Am Heart J. 2014 Mar;167(3):363-8.
Abstract

Menthol Cigarettes and the Cardiovascular Risks of People Living With HIV.
Míguez-Burbano MJ, Vargas M, Quiros C, et al
 J Assoc Nurses AIDS Care. 2014 Feb 26.
Abstract

Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.
Ketlogetswe KS, Post WS,  et al
AIDS. 2014 Jan 2.
 Abstract

Lipid Metabolism and Cardiovascular Risk in HIV Infection: New Perspectives and the Role of Nevirapine.
Podzamczer D.
AIDS Rev. 2013 Nov 6;15(4).
Abstract

Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients.
Lichtenstein KA, Armon C, Buchacz K,  et al
 Prev Chronic Dis. 2013 Jan;10
 Abstract

FULL-TEXT ARTICLE
 Psychological Factors, Including Alexithymia, in the Prediction of Cardiovascular Risk in HIV Infected Patients: Results of a Cohort Study.
Parruti G, Vadini F, Sozio F,  et al
PLoS One. 2013;8(1):e54555.
 Paper

Risk of Cardiovascular Events and Blood Pressure Control in Hypertensive HIV-Infected Patients: Swiss HIV Cohort Study (SHCS).
Nüesch R, Wang Q, Elzi L,  et al
J Acquir Immune Defic Syndr. 2013 Jan 2.
 Abstract

Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.
Kakinami L, Block RC, Adams MJ,  et al
Int J Clin Pract. 2013 Jan;67(1):6-13.
Abstract

FULL-TEXT ARTICLE
 Population-Based Study of Risk Factors for Coronary Heart Disease Among HIV-Infected Persons [United States}
Oh JY, Greene K, He H, et al
Open AIDS J. 2012;6:177-180
Paper

Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance
in HIV-infected patients.
Fabbiani M, Ciccarelli N, Tana M, et al
 HIV Med. 2012 Sep 21.
 Abstract

Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
Kaplan RC, Landay AL, Hodis HN, et al
J Acquir Immune Defic Syndr. 2012 May 15.
 Abstract

Cardiovascular Risk Factors and HIV Disease.
Fedele F, Bruno N, Mancone M.
AIDS Rev. 2011 Apr-Jun;13(2):119-29.
 Abstract

Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis
of coronary heart disease.
Butt AA, Chang CC, Kuller L, et al
Arch Intern Med. 2011 Apr 25;171(8):737-43.
 Abstract

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the
HIV-HEART study.
Reinsch N, Neuhaus K, Esser S,  et al
Eur J Cardiovasc Prev Rehabil. 2011 Feb 28
 Abstract

 HIV and General Cardiovascular Risk.
Capili B, Anastasi JK, Ogedegbe O.
J Assoc Nurses AIDS Care. 2011 Jan 28
 Abstract

Association of Vitamin D Insufficiency with Carotid Intima-Media Thickness in HIV-Infected Persons.
Choi AI, Lo JC, Mulligan K, et al
Clin Infect Dis. 2011 Jan 27
 Abstract

Role of biomarkers in predicting CVD risk in the setting of HIV infection?
Worm SW, Hsue P.|
Curr Opin HIV AIDS. 2010 Nov;5(6):467-72.
 Abstract

Reduction in coronary and peripheral vasomotor function in patients with HIV after
initiation of antiretroviral therapy: a longitudinal study with positron emission
tomography and flow-mediated dilation.
Kristoffersen US, Wiinberg N, Petersen CL, et al
Nucl Med Commun. 2010 Aug 7.
 Abstract

Low CD4(+) T Cell Count is a Risk Factor for Cardiovascular Disease Events in the HIV
Outpatient Study.
Lichtenstein KA, Armon C, Buchacz K,  et al
Clin Infect Dis. 2010 Jul 2
 Abstract

Association Between Kidney Function and Albuminuria With Cardiovascular Events
in HIV-Infected Persons.
Choi AI, Li Y, Deeks SG,  et al
Circulation. 2010 Jan 25.
 Abstract

          Conference Reports, Abstracts, and Posters

Pilot study to evaluate intramyocardial lipid accumulation in HIV+ patients receiving highly active antiretroviral therapy (HAART)
A.H. Conte, L. Szczepaniak, M. Nelson, et al
(XX International AIDS Conference)
 Abstract
Fat Redistribution
       

    Journal Papers, Abstracts, and Commentaries

 
Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons
Crum-Cianflone N, Krause D,
HIV Med. 2011 Jan 20. doi: 10.1111/j.1468-1293.2010.00904.
 Abstract
ARV Drugs
       

ARV Drugs: General

           Journal Papers, Abstracts, and Commentaries

 
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
 Baker JV, Sharma S, Achhra AC,  et al 
J Am Heart Assoc. 2017 May
Abstract


Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
 Baker JV, Sharma S, Achhra AC,  et al
 J Am Heart Assoc. 2017 May
Abstract

Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: A systematic review and meta-analysis.
Nduka C, Sarki A, Uthman O, Stranges S.  
Int J Cardiol. 2015 Jul 23;199:307-318. 
Abstract

FULL- TEXT ARTICLE
 Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review.
Bavinger C, Bendavid E, Niehaus K,  et al
PLoS One. 2013;8(3):e59551.
 Paper
Cocaine
       

         Journal Papers, Abstracts, and Commentaries 

 

Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk.
Lai H, Fishman EK, Gerstenblith G,  et al
Vasc Health Risk Manag. 2013;9:729-737.
Abstract.

Elevated LDL Cholesterol
       

         Journal Papers, Abstracts, and Commentaries        

 

FULL-TEXT ARTICLE
Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort.
Lang S, Lacombe JM, Mary-Krause M,
 PLoS One. 2015 Jul 22;10(7):e0133358.
 Paper

A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients.
 Feinstein MJ, Achenbach CJ, Stone NJ, Lloyd-Jones DM.
Am J Cardiol. 2015 Mar 24
 Abstract

LDL cholesterol levels and statin treatment by HIV status among MACS Men.
Monroe AK, Fu W, Zikusoka M,  et al
 AIDS Res Hum Retroviruses. 2015 Feb 9.
 Abstract

        Conference Reports, Abstracts, and Posters 

  LDL cholesterol and triglycerides levels are independent predictors of cardiovascular events in HIV-HCV co-infected patients: ANRS CO13-HEPAVIHB.
K. Tan, C. Gilbert, F. Bocarra, et al
 (XX International AIDS Conference)
 Abstract

 

HIV Cardiovascular Main Page Main New/Newsworthy  Home Page      

HIV Cardiovascular Disorders Risk Factors